Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy [NA]
A pilot study to evaluate the efficacy and safety of the NaviFUS System Neuromodulating Treatment for patients with drug-resistant epilepsy …
-
FDA approval · 2026-04-08FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for LEVETIRACETAM SOLUTION from Chartwell RX, LLC, granting approval under the ANDA process.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy [NA]
This update summarizes results from a completed trial evaluating the safety and potential therapeutic impact of transcranial direct current …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
A clinical trial update for a study aiming to improve diagnosis of epilepsy and influence long-term follow-up; the study is currently recrui…
-
EMA approval · 2026-04-08EMA Authorised: Fycompa (perampanel) — Eisai GmbH
The European Medicines Agency authorised Fycompa (perampanel) by Eisai GmbH for partial-onset seizures in epilepsy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Diagnosing Epilepsy To EffeCT Change [NA]
A clinical trial update shows a sponsor recruiting a study focused on diagnosing epilepsy, including treatment-refractory epilepsy.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Surgery as a Treatment for Medically Intractable Epilepsy
NINDS-sponsored trial is evaluating surgery as a treatment for medically intractable epilepsy, with recruitment currently ongoing.
-
FDA approval · 2026-04-08FDA Approved: VALPROIC ACID — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Valproic Acid from Bionpharma Inc., for a generic product under ANDA 073484. This action confirm…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy [EARLY_Phase 1]
An EARLY_PHASE1 clinical trial is evaluating everolimus as an adjunctive treatment for focal refractory epilepsy and is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy [NA]
This clinical trial update describes the 'Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy' program, a lifestyle-interventio…
-
CLINICAL_TRIALS withdrawal · 2026-04-06Clinical Trial Update: Intraoperative Brain Microdialysis to Assess Neuroinflammation in Epileptic Tissue Immediately Prior to Surgical Resection. [NA]
A Mayo Clinic-sponsored clinical trial evaluating intraoperative brain microdialysis to assess neuroinflammation in epileptic tissue before …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Reflexology on Seizure Frequency, Fatigue, Stress and Sleep Quality in Epilepsy Patients [NA]
This clinical trial update reports a completed study evaluating reflexology for effects on seizure frequency, fatigue, stress, and sleep qua…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Behavioral and Neuronal Correlates of Human Mood States [NA]
A Stanford University clinical trial investigating behavioral and neuronal correlates of mood states in adults with Major Depressive Disorde…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Investigating Epilepsy: Screening and Evaluation
A ClinicalTrials.gov entry shows that the NINDS-sponsored study on epilepsy screening and evaluation is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042 [Phase 1]
Phase 1 study evaluating the relative bioavailability of a new formulation of NPT 2042 compared to the original formulation; the study has c…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS [NA]
A University of Minnesota-led study is recruiting to evaluate vagal excitation and its anatomical connections in epilepsy and major depressi…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes [NA]
A clinical trial sponsored by Anny Reyes aims to educate patients on social determinants of health to improve epilepsy surgery access and ou…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: An Observational Study of the NeuroBell EEG Monitor
The study reports completion of an observational evaluation of the NeuroBell EEG Monitor in neonatal patients with seizures and related neur…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment [Phase 3]
A roll-over Phase 3 study is being conducted to collect long-term safety data for everolimus in patients with tuberous sclerosis complex and…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Treatment: a Pilot Study [NA]
A pilot clinical trial evaluating a care pathway that combines remote monitoring with nurse support after a change in anti-epileptic therapy…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Subcortical Arousal in Perceptual Awareness [NA]
A Yale University–led clinical trial investigating subcortical arousal in perceptual awareness for epilepsy is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders
The clinical trial evaluating a multidisciplinary expert system for assessment and management of complex brain disorders has completed.
-
FDA approval · 2026-04-01FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Lamotrigine from Sun Pharmaceutical Industries, Inc.
-
EMA approval · 2026-04-01EMA Authorised: Keppra (levetiracetam) — UCB Pharma SA
Keppra (levetiracetam) has been authorised in the EU for epilepsy. The marketing authorization holder is UCB Pharma SA.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies
A clinical trial is recruiting to improve diagnosis and treatment for drug-resistant focal epilepsies.